WO2024084462 - NUCLEIC ACID COMPLEXES AND USES THEREOF
National phase entry:
Publication Number
WO/2024/084462
Publication Date
25.04.2024
International Application No.
PCT/IB2023/060639
International Filing Date
20.10.2023
Title **
[English]
NUCLEIC ACID COMPLEXES AND USES THEREOF
[French]
COMPLEXES D'ACIDE NUCLÉIQUE ET LEURS UTILISATIONS
Applicants **
BIONTECH SE
Inventors
MORENO HERRERO, Jorge
HAAS, Heinrich
ERBAR, Stephanie
STAHL, Theo Benjamin
Priority Data
PCT/IB2022/060153
21.10.2022
IB
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2359 | |
| EPO | Filing, Examination, Granting | 10203 | |
| Japan | Filing, Examination, Granting | 2223 | |
| South Korea | Filing, Examination, Granting | 2180 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
21,705
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure provides complexes and uses thereof, wherein the complex comprises a first cationic polymer, a second cationic polymer, and a monomeric RNA molecule, wherein the first cationic polymer comprises greater than 250 repeating monomer units, and the second cationic polymer comprises 200 repeating monomer units, or less.[French]
La présente invention concerne des complexes et leurs utilisations, le complexe comprenant un premier polymère cationique, un second polymère cationique et une molécule d'ARN monomère, le premier polymère cationique comprenant plus de 250 unités monomères répétitives, et le second polymère cationique comprenant 200 unités monomères répétitives, ou moins.